Glenmark Pharmaceuticals recalls 75mg Indomethacin Extended-Release Capsules due to CGMP deviations. Affected lots may pose quality risks; contact for details.
CGMP Deviations
Glenmark is recalling 75mg Indometh: 60-count bottles made in India with specific lot numbers. The recall is due to manufacturing quality issues that could affect product safety.
CGMP deviations mean the manufacturing process didn't meet quality standards. This could lead to inconsistent drug strength or safety issues, but the exact risk isn't specified in the recall.
People who bought these capsules from pharmacies or online retailers between the specified dates. Those with chronic pain conditions using the medication are most at risk.
Check for the NDC code 68462-325-60 on the bottle. Look for lot numbers 17232323 or 17232335 with expiration dates of October 2025.
Look for the NDC code 68462-325-60 and lot numbers 17232323 or 17232335 on the bottle.
The recall is due to CGMP deviations, which are manufacturing quality issues that could affect product safety.
The official notice doesn't specify a remedy, so contact Glenmark Pharmaceuticals for further instructions.
Yes, lot numbers 17232323 and 17232335 with expiration dates of October 2025 are affected.
We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.
Subject: Recall D-0329-2025 — Glenmark Glenmark Hello, I own a Glenmark that is covered by recall D-0329-2025 from Glenmark. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
